Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer

BACKGROUND: Strict eligibility criteria for patient enrollment in phase III trials raise questions regarding generalization to ineligible patients. We evaluated whether pivotal phase III trials of immune checkpoint blockades (ICBs) represent the overall population of non‐small cell lung cancer (NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Shin Hye, Keam, Bhumsuk, Kim, Miso, Kim, Tae Min, Kim, Dong‐Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456815/
https://www.ncbi.nlm.nih.gov/pubmed/29682899
http://dx.doi.org/10.1111/1759-7714.12641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456815/
https://www.ncbi.nlm.nih.gov/pubmed/29682899
http://dx.doi.org/10.1111/1759-7714.12641

Ejemplares similares